ArticleNeurotoxicity research2025
Dysregulation of Mitochondrial Iron Regulators as a Basis of Iron-Mediated Retinal Degeneration in Rats.
Article in Neurotoxicity research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Iron accumulates with aging. This triggers various pathological changes and diseases. We studied the impact of iron administration on mitochondrial iron metabolism in the retina. Control, four-month-old, male Wistar rats (n = 27) received either sterile distilled water (4MC) or ferrous sulphate (500 mg/kg body weight/week) by gavage until 12 months of age (12ME group). Another group of rats, receiving distilled water, was raised until 12 months and served as age-matched control (12MC). We examined the body weight, liver and retinal iron levels, retinal glutathione levels, histology, TEM, immunohistochemistry, and Western blotting of glutathione peroxidase-4 (a marker of ferroptosis), procaspase-3 and mitochondrial ferritin and frataxin, involved in iron regulation. In 12ME rats, there were elevated iron levels in the liver and retina, and decreased retinal glutathione levels, compared to that in 12MC rats. Prussian blue staining and iron estimation indicated iron accumulation in the liver and retina. There was marked degeneration of the retinal pigment epithelium and photoreceptor cells, resulting in gliosis, as seen by GFAP immunolabeling. Western blotting showed decreased levels of mitochondrial ferritin and frataxin, suggesting iron-induced mitochondrial dysfunction, while a decrease in glutathione levels and glutathione peroxidase-4 expression, and lack of expression of active caspase-3 (a marker of apoptosis) indicated an iron-dependent, non-apoptotic mode of retinal cell death (ferroptosis). Despite the smaller sample size in some assays (histopathology), our data show significant pathological changes of the retina due to iron accumulation at 12-month age of rats, and that dysregulation of the mitochondrial iron homeostasis is a step involved in iron-mediated retinal degeneration with aging.
Indexed as
Identifiers
40512285What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.